TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Congress Agrees On Jackson Lab Support, But does Not Add Money; Earmarks Hit NCI Budget October 27, 1989
TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007
TCL Archive NCI Board of Scientific Advisors also approved a new SBIR grant program for research on circulating cells in cancer detection. March 26, 2004
